In this study, the serum indices of NSE, CA125, and CEA were visibly decreased after treatment, suggesting that the above indices were negatively correlated with the therapeutic efficacy, which could be used as important indicators for monitoring the evaluation of therapeutic effect in advanced SCLC. The gene discussed is CEACAM5; the disease is small cell lung carcinoma.